0.8039
price down icon0.22%   -0.0018
after-market Dopo l'orario di chiusura: .84 0.0361 +4.49%
loading

X 4 Pharmaceuticals Inc Azioni (XFOR) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
47.98%
37.29
25.20 27.21 25.80 29.30
Interest Income/Expense
0.64%
1.874
1.886 1.634 1.148 1.109
Operating Income/Loss
47.98%
-37.29
-25.20 -27.21 -25.80 -29.30
Nonoperating Income/Loss
336.94%
-14.46
6.102 24.93 -29.89 5.288
Income/Loss From Continuing Operations Before Tax
170.97%
-51.75
-19.10 -2.279 -55.70 -24.02
Income Tax Expense/Benefit
42.42%
0.019
0.033 0.026 0.015 0.004
Income/Loss From Continuing Operations After Tax
170.60%
-51.77
-19.13 -2.305 -55.71 -24.02
Net Income/Loss
170.60%
-51.77
-19.13 -2.305 -55.71 -24.02
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,732%
199.99
7.0615 196.99 168.74 145.97
Diluted Average Shares
2,732%
199.99
7.0615 196.99 168.74 145.97
Basic Earnings Per Share
188.89%
-0.26
-0.09 -0.01 -0.33 -0.16
Diluted Earnings Per Share
188.89%
-0.26
-0.09 -0.01 -0.33 -0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.02
price up icon 2.14%
$18.21
price down icon 5.55%
$40.13
price down icon 0.74%
$359.96
price down icon 1.14%
$181.89
price down icon 1.51%
$113.95
price up icon 0.16%
Capitalizzazione:     |  Volume (24 ore):